Literature DB >> 26681771

Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.

Robert M Stoekenbroek1, S Matthijs Boekholdt2, Robert Luben3, G Kees Hovingh4, Aeilko H Zwinderman5, Nicholas J Wareham6, Kay-Tee Khaw3, Ron J G Peters7.   

Abstract

AIMS: Particular atherosclerotic risk factors may differ in their association with atherosclerosis across vascular territories. Few studies have compared the associations between multiple risk factors and cardiovascular disease (CVD) manifestations in one population. We studied the strength of the associations between traditional risk factors including coronary artery disease (CAD), ischaemic and haemorrhagic stroke, abdominal aortic aneurysms (AAAs), and peripheral arterial disease (PAD). METHODS AND
RESULTS: This analysis included 21 798 participants of the EPIC-Norfolk population study, without previous CVD. Events were defined as hospitalization or mortality, coded using ICD-10. The associations between the risk factors, such as low-density lipoprotein cholesterol, systolic blood pressure (SBP), and smoking, and the various CVD manifestations were compared using competing risk analyses. During 12.1 years, 3087 CVD events were recorded. The associations significantly differed across CVD manifestations. Low-density lipoprotein cholesterol was strongly associated with CAD [adjusted hazard rate (aHR) highest vs. lowest quartile 1.63, 95% CI 1.44-1.86]. Systolic blood pressure was a strong risk factor for PAD (aHR highest vs. lowest quartile 2.95, 95% CI 1.78-4.89) and ischaemic stroke (aHR highest vs. lowest quartile 2.48, 95% CI 1.55-3.97), but not for AAA. Smoking was strongly associated with incident AAA (aHR current vs. never 7.66, 95% CI 4.50-13.04) and PAD (aHR current vs. never 4.66, 95% CI 3.29-6.61), but not with haemorrhagic stroke.
CONCLUSION: The heterogeneity in the risk factor-CVD associations supports the concept of pathophysiological differences between atherosclerotic CVD manifestations and could have implications for CVD prevention. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiovascular disease; Pathophysiology; Prevention; Risk factors

Mesh:

Substances:

Year:  2015        PMID: 26681771     DOI: 10.1093/eurheartj/ehv630

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  14 in total

1.  Low-Density Lipoprotein Cholesterol and Risk of Hemorrhagic Stroke: a Systematic Review and Dose-Response Meta-analysis of Prospective Studies.

Authors:  Chaoran Ma; Muzi Na; Samantha Neumann; Xiang Gao
Journal:  Curr Atheroscler Rep       Date:  2019-11-20       Impact factor: 5.113

2.  Association of Mitochondrial DNA Copy Number With Cardiovascular Disease.

Authors:  Foram N Ashar; Yiyi Zhang; Ryan J Longchamps; John Lane; Anna Moes; Megan L Grove; Josyf C Mychaleckyj; Kent D Taylor; Josef Coresh; Jerome I Rotter; Eric Boerwinkle; Nathan Pankratz; Eliseo Guallar; Dan E Arking
Journal:  JAMA Cardiol       Date:  2017-11-01       Impact factor: 14.676

3.  Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis.

Authors:  Brian T Steffen; George Thanassoulis; Daniel Duprez; James H Stein; Amy B Karger; Mathew C Tattersall; Joel D Kaufman; Weihua Guan; Michael Y Tsai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

4.  Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: A prospective study.

Authors:  Chaoran Ma; M Edip Gurol; Zhe Huang; Alice H Lichtenstein; Xiuyan Wang; Yuzhen Wang; Samantha Neumann; Shouling Wu; Xiang Gao
Journal:  Neurology       Date:  2019-07-02       Impact factor: 9.910

Review 5.  Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988).

Authors:  Maciej Banach; Niloofar Shekoohi; Dimitri P Mikhailidis; Gregory Y H Lip; Adrian V Hernandez; Mohsen Mazidi
Journal:  Arch Med Sci       Date:  2022-01-19       Impact factor: 3.707

6.  Unsupervised Learning for Automated Detection of Coronary Artery Disease Subgroups.

Authors:  Alyssa M Flores; Alejandro Schuler; Anne Verena Eberhard; Jeffrey W Olin; John P Cooke; Nicholas J Leeper; Nigam H Shah; Elsie G Ross
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 6.106

7.  Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study.

Authors:  Sophie J Bernelot Moens; Robert M Stoekenbroek; Fleur M van der Valk; Simone L Verweij; Mark J W Koelemay; Hein J Verberne; Max Nieuwdorp; Erik S G Stroes
Journal:  BMC Cardiovasc Disord       Date:  2016-11-25       Impact factor: 2.298

8.  Editor's Choice - Calcification of Thoracic and Abdominal Aneurysms is Associated with Mortality and Morbidity.

Authors:  Mohammed M Chowdhury; Lukasz P Zieliński; James J Sun; Simon Lambracos; Jonathan R Boyle; Seamus C Harrison; James H F Rudd; Patrick A Coughlin
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-12-07       Impact factor: 7.069

9.  Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy.

Authors:  Sandra Mastroianno; Giuseppe Di Stolfo; Davide Seripa; Michele Antonio Pacilli; Giulia Paroni; Carlo Coli; Maria Urbano; Carmela d'Arienzo; Carolina Gravina; Domenico Rosario Potenza; Giovanni De Luca; Antonio Greco; Aldo Russo
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

10.  The Dutch SCORE-based risk charts seriously underestimate the risk of cardiovascular disease.

Authors:  H T Jørstad; S M Boekholdt; N J Wareham; K T Khaw; R J G Peters
Journal:  Neth Heart J       Date:  2017-03       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.